Europe
Expedeon AG signs supply agreement with Reszon Diagnostics for proprietary colloidal gold technology
Expedeon’s proprietary colloidal gold to be used for manufacturing of diagnostic lateral flow assays
Oral alicaforsen appears safe and well-tolerated
Accelerates sharing of genomic and health data from more than 150.000 subjects
Clinigen Group plc has agreed to acquire iQone Healthcare Holding, a privately owned Swiss based speciality pharmaceutical business for an initial consideration of €7.5 million (£6.7 million) on a cash free, debt free basis.
Accretive acquisition significantly strengthens Clinigen’s competitive positioning with specialist packaging, labelling, warehousing and distribution capabilities in Europe & the US
Clinigen Group plc has today published its full year results for the year ended 30 June 2018.
Immunicum AB (publ; IMMU.ST) today announced that Company leadership will present at upcoming regulatory affairs, industry and scientific conferences in October.
The financing round will be used to progress development pipeline based on the key bacterial symbiont Akkermansia muciniphila
GENFIT today provides further details on the management changes announced in its September 24, 2018 press release.
Adocia today announced that five abstracts featuring applications of its BioChaperone® platform technology have been accepted for presentation at the 54th Annual Meeting of the European Association for the Study of Diabetes (EASD) being held October 1-5, 2018 in Berlin, Germany.
PRESS RELEASES